CURR VASC PHARMACOL 润色咨询

Current Vascular Pharmacology

出版年份:2003 年文章数:14 投稿命中率:50.0%

出版周期:Quarterly 自引率:10.1% 审稿周期:平均2月

前往期刊查询

投稿信息

投稿信息
审稿速度
平均2月 (网友贡献,非官方数据)
投稿命中率
50.0% (网友贡献,非官方数据)
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2022年中国人文章占该期刊总数量7.27% (2019年为2.99%)
自引率
10.1 %
年文章数
14
期刊官网
点击查看 (点击次数:5436)
点击查看 (点击次数:1132次)
作者需知
暂无数据
期刊简介
稿件收录要求
Published by Bentham Science Publishers. ISSN: 1570-1611.

Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention (e.g. for symptomatic relief). Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials. Vascular disease is a complex field with primary care physicians and nurse practitioners as well as several specialties involved. The latter include cardiology, vascular and cardio thoracic surgery, general medicine, radiology, clinical pharmacology and neurology (stroke units). Current Vascular Pharmacology will publish reviews to update all those concerned with the treatment of vascular disease. For example, reviews commenting on recently published trials or new drugs will be included. In addition to clinically relevant topics we will consider 'research-based' reviews dealing with future developments and potential drug targets. Therefore, another function of Current Vascular Pharmacology is to bridge the gap between clinical practice and ongoing research. Debates will also be encouraged in the correspondence section of this journal.